Independent Lab Verified|≥98% Purity Guarantee|Shipped Within 24hrs|Research Use Only|International Shipping|North American Made|Free Shipping $149 USD+|Independent Lab Verified|≥98% Purity Guarantee|Shipped Within 24hrs|Research Use Only|International Shipping|North American Made|Free Shipping $149 USD+|Independent Lab Verified|≥98% Purity Guarantee|Shipped Within 24hrs|Research Use Only|International Shipping|North American Made|Free Shipping $149 USD+|Independent Lab Verified|≥98% Purity Guarantee|Shipped Within 24hrs|Research Use Only|International Shipping|North American Made|Free Shipping $149 USD+|
peptide dosing

ACE-031 Dosing & Reconstitution Guide

Complete dosing reference for ACE-031 (Muscle Growth / Research). Covers reconstitution, dose range, titration schedule, pharmacokinetics, and storage protocols for research use.

Dosing Protocol

Route: Subcutaneous injection (DISCONTINUED CLINICAL PROGRAM) Frequency: Once every 2 weeks (from clinical trial protocol) Dose Range: 0.5-3 mg/kg every 2 weeks (clinical trial doses) Cycle Length: Clinical trials ran 12-24 weeks Timing: Any time of day

Titration Schedule

Clinical protocol: 1-3 mg/kg SC every 14 days

Storage

Lyophilized: Freeze at -20 °C or below Reconstituted: Refrigerate 2-8 °C, use within 24 hours

Injection Sites

Abdomen, Thigh

Safety & Contraindications

Safety: CRITICAL: Vascular safety signals led to clinical discontinuation Epistaxis (nosebleeds) in multiple subjects Telangiectasias (dilated blood vessels in skin/mucosa)

Contraindications: History of hereditary hemorrhagic telangiectasia (HHT); Bleeding disorders; Vascular malformations

Frequently Asked Questions

Explore More

Research Use Only. The information on this page is compiled from published research literature and is provided for educational purposes only. It does not constitute medical advice. All compounds referenced are intended for in vitro research use by qualified laboratories and institutions.

Your Cart

Your cart is empty

Browse our catalog to add research compounds.